Grandview Asset Management LLC Edwards Lifesciences Corp Transaction History

Grandview Asset Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$83.84 - $104.76 $110,249 - $137,759	-1,315 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$78.68 - $90.67 $92,212 - $106,265	1,172 Added 819.58%	1,315 $110,000
Q1 2021 May 06, 2021	BUY	$78.68 - $90.67 $11,251 - $12,965	143 New	143 $5,000
Q1 2020 Apr 09, 2020	SELL	$52.41 - $81.0 $586,939 - $907,119	-11,199 Closed	0 $0
Q4 2019 Jan 28, 2020	SELL	$71.7 - $82.09 $104,180 - $119,276	-1,453 Reduced 11.48%	11,199 $2.6 Million
Q3 2019 Nov 07, 2019	BUY	$61.55 - $75.43 $17,603 - $21,572	286 Added 2.31%	12,652 $2.72 Million
Q2 2019 Jul 18, 2019	SELL	$55.74 - $64.41 $34,893 - $40,320	-626 Reduced 4.82%	12,366 $2.28 Million
Q1 2019 May 07, 2019	BUY	$47.89 - $64.05 $5,076 - $6,789	106 Added 0.82%	12,992 $2.49 Million
Q4 2018 Feb 05, 2019	BUY	$46.41 - $56.94 $598,039 - $733,728	12,886 New	12,886 $1.97 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Grandview Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Grandview Asset Management LLC with notifications on news.